151 related articles for article (PubMed ID: 8971741)
1. Cannabinoid receptor-mediated inhibition of dopamine release in the retina.
Schlicker E; Timm J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Dec; 354(6):791-5. PubMed ID: 8971741
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain.
Kathmann M; Bauer U; Schlicker E; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta.
Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice.
Kathmann M; Weber B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors.
Nakazi M; Bauer U; Nickel T; Kathmann M; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jan; 361(1):19-24. PubMed ID: 10651142
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus.
Schlicker E; Timm J; Zentner J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):583-9. PubMed ID: 9402037
[TBL] [Abstract][Full Text] [Related]
7. Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs.
Schlicker E; Schunack W; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1990 Nov; 342(5):497-501. PubMed ID: 1965325
[TBL] [Abstract][Full Text] [Related]
8. Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein-coupled receptors.
Weber B; Schlicker E
Fundam Clin Pharmacol; 2001 Dec; 15(6):393-400. PubMed ID: 11860527
[TBL] [Abstract][Full Text] [Related]
9. H2 receptor-mediated facilitation and H3 receptor-mediated inhibition of noradrenaline release in the guinea-pig brain.
Timm J; Marr I; Werthwein S; Elz S; Schunack W; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):232-9. PubMed ID: 9550293
[TBL] [Abstract][Full Text] [Related]
10. Enhanced acetylcholine release in the hippocampus of cannabinoid CB(1) receptor-deficient mice.
Kathmann M; Weber B; Zimmer A; Schlicker E
Br J Pharmacol; 2001 Mar; 132(6):1169-73. PubMed ID: 11250865
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus.
Coutts AA; Pertwee RG
Br J Pharmacol; 1997 Aug; 121(8):1557-66. PubMed ID: 9283688
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid CB1 receptor-mediated inhibition of the neurogenic vasopressor response in the pithed rat.
Malinowska B; Godlewski G; Bucher B; Schlicker E
Naunyn Schmiedebergs Arch Pharmacol; 1997 Aug; 356(2):197-202. PubMed ID: 9272725
[TBL] [Abstract][Full Text] [Related]
13. Lack of CB1 receptors increases noradrenaline release in vas deferens without affecting atrial noradrenaline release or cortical acetylcholine release.
Schlicker E; Redmer A; Werner A; Kathmann M
Br J Pharmacol; 2003 Sep; 140(2):323-8. PubMed ID: 12970076
[TBL] [Abstract][Full Text] [Related]
14. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
Steffens M; Szabo B; Klar M; Rominger A; Zentner J; Feuerstein TJ
Neuroscience; 2003; 120(2):455-65. PubMed ID: 12890515
[TBL] [Abstract][Full Text] [Related]
15. Identification of the dopamine autoreceptor in the guinea-pig retina as D(2) receptor using novel subtype-selective antagonists.
Weber B; Schlicker E; Sokoloff P; Stark H
Br J Pharmacol; 2001 Aug; 133(8):1243-8. PubMed ID: 11498509
[TBL] [Abstract][Full Text] [Related]
16. WIN-55,212-2 and SR-141716A alter nicotine-induced changes in locomotor activity, but do not alter nicotine-evoked [3H]dopamine release.
Rodvelt KR; Bumgarner DM; Putnam WC; Miller DK
Life Sci; 2007 Jan; 80(4):337-44. PubMed ID: 17067637
[TBL] [Abstract][Full Text] [Related]
17. A search for presynaptic beta3-adrenoceptors in the rat.
Zelaszczyk D; Zakrzeska A; Kwolek G; Malinowska B; Schlicker E
Fundam Clin Pharmacol; 2005 Apr; 19(2):147-53. PubMed ID: 15810894
[TBL] [Abstract][Full Text] [Related]
18. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
Gifford AN; Samiian L; Gatley SJ; Ashby CR
Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
[TBL] [Abstract][Full Text] [Related]
19. Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors.
Mayer A; Limberger N; Starke K
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):632-43. PubMed ID: 2907613
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective h5-HT1B (SB-216641) and h5-HT1D (BRL-15572) receptor ligands on guinea-pig and human 5-HT auto- and heteroreceptors.
Schlicker E; Fink K; Molderings GJ; Price GW; Duckworth M; Gaster L; Middlemiss DN; Zentner J; Likungu J; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):321-7. PubMed ID: 9303568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
